Zealthy and infertility in India

The average infertility rate in Indian married couples is around 10-15% Of which only 45% visit a doctor for help and a mere 1% receive infertility treatments. Zealthy is deciding to change how women deal with reproductive health.

Infertility is a problem that globally affects around 15% of all reproductive-age couples. The World Health Organisation (WHO) says that the prevalence of primary infertility in India is between 3.9 to 16.8%. A research conducted by Inito, a Bengaluru-based firm, claims that the average infertility rate in Indian married couples is around 10-15% Within such couples, only 45% visit a doctor for help and a mere 1% receive infertility treatments. A majority of couples rely on homemade remedies and other options that are not clinically proven. 

A huge reason is that there is a lack of awareness in women regarding their reproductive health. To bridge this gap, Akhil Gupta and Rishi Malhotra founded Zealthy in 2018. Zealthy is a health company dedicated to helping women make informed decisions regarding their reproductive health, in areas like fertility and pregnancy. Their offerings are FSSAI and ISO approved and clinically proven. 

The Banglore-based startup offers services and support even for period-related problems like menopause, PCOS (Polycystic Ovary Syndrome) and other conditions. They also provide treatments like IVF, IUI, Surrogacy, Laparoscopy and Hysteroscopy. 

They have partnered with 150+ healthcare players including Apollo Cradle, Milann, Morpheus, Motherhood, and other maternity homes. Since its inception, they have helped over 10,000 mothers with pregnancy. They are currently present in 50+ cities and aim to establish themselves in 150 cities. Zealthy’s parent company, Zuddy Healthtech has raised an undisclosed amount from KYT Ventures, First Cheque, AngelList and other angel investors like MPL’s Shubham Malhotra and former SoftBank director Pavan Ongole. 

The company was generating 5x revenue in August 2020 and they plan to reach Rs 1 crore per month in the coming days and enter tier 2 and tier 3 cities. They also want to expand from English and Hindi into regional languages like Bengali, Tamil, Telugu and Malayalam.

Will Zealthy be able to show growth despite severe competition in the women health segment from Healofy and BabyChakra and even in the women-based e-commerce space with competitors like Nua, PeeSafe, Azah and others?

Tags : #Zealthy #AkhilGupta #RishiMalhotra #womenreproductivehealth #infertility #pregnancy #infertilitytreatments #MediSpeak #smitakumar #medicircle

Related Stories

Loading Please wait...

Trending Now

China ropes in more countries for its COVID-19 vaccine trialsSeptember 29, 2020
Antarctica is still free of Covid-19. Can it stay that way?September 29, 2020
Over 200 travellers from India barred from Dubai flight over invalid Covid-19 testsSeptember 29, 2020
Netherland focuses on more stricker rule to comabt COVID-19 September 29, 2020
WHO aims to provide 120 Million rapid Coronavirus tests for poorer statesSeptember 29, 2020
UN chief on 1 Million COVID-19 deathsSeptember 29, 2020
Bahrain reports 585 Covid-19 cases, 777 recoveriesSeptember 28, 2020
Bringing hepatitis C testing and treatment to underserved communities in MadridSeptember 28, 2020
Polish doctor recovers from severe COVID-19 through rehabilitationSeptember 28, 2020
WHO supports rehabilitation of COVID-19 and other patients in UkraineSeptember 28, 2020
WHO work with migrant camps in Greece September 28, 2020
US employers being sued for COVID-19 infection spread September 28, 2020
Global Coronavirus deaths cross 1 Million markSeptember 28, 2020
Highly effective antibodies identified, may lead to passive COVID-19 vaccineSeptember 26, 2020
Europe has a lot of work to do to prevent COVID-19 transmission :WHOSeptember 26, 2020
Two million Coronavirus deaths : WHO September 26, 2020
Johnson & Johnson COVID-19 vaccine produces strong results September 26, 2020
New York to permanently switch to outdoor dining amid pandemicSeptember 26, 2020
WHO gave blessing for Coronavirus vaccine emergency use programme: ChinaSeptember 26, 2020
US surpasses 7 Million Coronavirus casesSeptember 26, 2020